135 related articles for article (PubMed ID: 35961146)
1. Distinct phenotypic spectra of hepatocellular carcinoma in liver-specific tumor suppressor-deficient hepatitis B virus transgenic mice.
Tarnow G; Matrenec R; Oropeza CE; Maienschein-Cline M; McLachlan A
Virology; 2022 Sep; 574():84-95. PubMed ID: 35961146
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.
Oropeza CE; Ondracek CR; Tarnow G; Maienschein-Cline M; Green SJ; McLachlan A
Virology; 2022 Jan; 566():16-25. PubMed ID: 34844082
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
4. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis.
Chung YL; Wu ML
J Pathol; 2013 Aug; 230(4):377-87. PubMed ID: 23620081
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.
Vivekanandan P; Torbenson M; Ramakrishna B
J Gastrointest Cancer; 2011 Mar; 42(1):20-5. PubMed ID: 20963515
[TBL] [Abstract][Full Text] [Related]
6. PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.
Huang F; Guo J; Zhao N; Hou M; Gai X; Yang S; Cai P; Wang Y; Ma Q; Zhao Q; Li L; Yang H; Jing Y; Jin D; Hu Z; Zha X; Wang H; Mao Y; Liu F; Zhang H
J Transl Med; 2024 Mar; 22(1):254. PubMed ID: 38459588
[TBL] [Abstract][Full Text] [Related]
7. HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
Huang P; Xu Q; Yan Y; Lu Y; Hu Z; Ou B; Zhang H; Mao K; Zhang J; Wang J; Xiao Z
Oncogene; 2020 Apr; 39(18):3774-3789. PubMed ID: 32157216
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.
Liu Y; Qi X; Zeng Z; Wang L; Wang J; Zhang T; Xu Q; Shen C; Zhou G; Yang S; Chen X; Lu F
Sci Rep; 2017 Jun; 7(1):2796. PubMed ID: 28584302
[TBL] [Abstract][Full Text] [Related]
9. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma.
Fu Y; Fang F; Guo H; Xiao X; Hu Y; Zeng Y; Chen T; Wu S; Lin N; Huang J; Jiang L; Ou Q; Liu C
Emerg Microbes Infect; 2022 Dec; 11(1):2486-2501. PubMed ID: 36102940
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
Wu MH; Ma WL; Hsu CL; Chen YL; Ou JH; Ryan CK; Hung YC; Yeh S; Chang C
Sci Transl Med; 2010 May; 2(32):32ra35. PubMed ID: 20484730
[TBL] [Abstract][Full Text] [Related]
12. HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma.
He Z; Zhu J; Mo J; Zhao H; Chen Q
Mol Med Rep; 2020 Jul; 22(1):380-386. PubMed ID: 32319639
[TBL] [Abstract][Full Text] [Related]
13. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.
Kim YR; Byun MR; Choi JW
Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110
[TBL] [Abstract][Full Text] [Related]
14. Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.
Lim HC; Gordan JD
PLoS Comput Biol; 2021 Feb; 17(2):e1008699. PubMed ID: 33561166
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection.
Saitta C; Lanza M; Bertuccio A; Lazzara S; Navarra G; Raimondo G; Pollicino T
Cancer Genet; 2015 Oct; 208(10):513-6. PubMed ID: 26341700
[TBL] [Abstract][Full Text] [Related]
18. β-Catenin Signaling Regulates the
Tarnow G; McLachlan A
J Virol; 2021 Sep; 95(20):e0078021. PubMed ID: 34319157
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]